Fortis Healthcare
- Advice
- Hold
Fortis Healthcare Performance
Day Range
- Low 380.00
- High 384.50
52 Week Range
- Low 245.50
- High 390.00
- Open Price383.00
- Previous Close385.55
- Volume1682641
Start SIP in Fortis Healthcare
Start SIPFortis Healthcare Investment Rating
-
Master Rating:
-
Fortis Healthcare (Nse) has an operating revenue of Rs. 6,629.94 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 13% is healthy, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 10% and 24% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 10% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 25 which is a POOR score indicating inconsistency in earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 294 | 289 | 277 | 262 | 266 | 247 | 210 |
Operating Expenses Qtr Cr | 255 | 254 | 250 | 226 | 228 | 215 | 191 |
Operating Profit Qtr Cr | 40 | 35 | 28 | 36 | 38 | 32 | 19 |
Depreciation Qtr Cr | 25 | 25 | 29 | 29 | 29 | 28 | 28 |
Interest Qtr Cr | 21 | 23 | 25 | 25 | 28 | 28 | 33 |
Tax Qtr Cr | 8 | 5 | 1 | 4 | 4 | 3 | -2 |
Net Profit Qtr Cr | 95 | 13 | 2 | 19 | 82 | -8 | -24 |
Fortis Healthcare Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹371.56
- 50 Day
- ₹355.01
- 100 Day
- ₹339.88
- 200 Day
- ₹320.62
- 20 Day
- ₹372.18
- 50 Day
- ₹348.86
- 100 Day
- ₹339.98
- 200 Day
- ₹309.75
Fortis Healthcare Resistance and Support
Resistance | |
---|---|
First Resistance | 384.37 |
Second Resistance | 386.68 |
Third Resistance | 388.87 |
RSI | 65.07 |
MFI | 68.10 |
MACD Single Line | 11.17 |
MACD | 11.56 |
Support | |
---|---|
First Resistance | 379.87 |
Second Resistance | 377.68 |
Third Resistance | 375.37 |
Fortis Healthcare Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 592,135 | 29,713,334 | 50.18 |
Week | 1,697,127 | 114,810,655 | 67.65 |
1 Month | 1,996,751 | 122,141,267 | 61.17 |
6 Month | 1,744,677 | 119,318,488 | 68.39 |
Fortis Healthcare Result Highlights
Fortis Healthcare Synopsis
NSE-Medical-Hospitals
Fortis Healthcare is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 1052.93 Cr. and Equity Capital is Rs. 754.96 Cr. for the Year ended 31/03/2023. Fortis Healthcare Ltd. is a Public Limited Listed company incorporated on 28/02/1996 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L85110PB1996PLC045933 and registration number is 045933.Market Cap | 28,839 |
Sales | 1,123 |
Shares in Float | 52.09 |
No of funds | 265 |
Yield | 0.26 |
Book Value | 3.25 |
U/D Vol ratio | 1.4 |
LTDebt / Equity | 3 |
Alpha | 0.11 |
Beta | 0.39 |
Fortis Healthcare
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 31.17% | 31.17% | 31.17% | 31.17% |
Mutual Funds | 22.5% | 18.49% | 17.38% | 17.5% |
Insurance Companies | 2.8% | 2.39% | 2.07% | 1.64% |
Foreign Portfolio Investors | 26.31% | 30.03% | 31.22% | 31.01% |
Financial Institutions/ Banks | 1.19% | 1.2% | 1.19% | 1.19% |
Individual Investors | 11.13% | 11.81% | 12.06% | 12.39% |
Others | 4.9% | 4.91% | 4.91% | 5.1% |
Fortis Healthcare Management
Name | Designation |
---|---|
Mr. Ravi Rajagopal | Chairman & Ind.Director |
Dr. Ashutosh Raghuvanshi | Managing Director & CEO |
Ms. Suvalaxmi Chakraborty | Independent Director |
Mr. Indrajit Banerjee | Independent Director |
Ms. Shailaja Chandra | Independent Director |
Mr. Tomo Nagahiro | Non Executive Director |
Mr. Dilip Kadambi | Non Executive Director |
Mr. Heng Joo Joe Sim | Non Executive Director |
Mr. Lim Tsin Lin | Non Executive Director |
Mr. Mehmet Ali Aydinlar | Non Executive Director |
Mr. Joerg Ayrle | Non Executive Director |
Fortis Healthcare Forecast
Price Estimates
Fortis Healthcare Corporate Action
Fortis Healthcare FAQs
What is Share Price of Fortis Healthcare ?
Fortis Healthcare share price is ₹382 As on 08 December, 2023 | 17:31
What is the Market Cap of Fortis Healthcare ?
The Market Cap of Fortis Healthcare is ₹28843.2 Cr As on 08 December, 2023 | 17:31
What is the P/E ratio of Fortis Healthcare ?
The P/E ratio of Fortis Healthcare is 52.7 As on 08 December, 2023 | 17:31
What is the PB ratio of Fortis Healthcare ?
The PB ratio of Fortis Healthcare is 3.6 As on 08 December, 2023 | 17:31